Trending stocks today
CVS Health Corp (CVS-N)
308 watching
NYSE:CVS
100.80
0.46
(0.45%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
Nov 28, 2022, 5:52 pm
0
TOP PICK
CVS Health is a different kind of health care company. It is a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, it is meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, its diversified model engages one in three Americans each year. From its innovative new services at HealthHUB locations, to transformative programs that help manage chronic conditions, it is making health care more accessible, more affordable and simply better. Social media mentions are up 560% in the past 24h.
specialty stores
$95.490
Unknown
DON'T BUY
Company has seen turmoil the past year.
Healthcare will be a strong sector going forward.
Better companies in this space.
specialty stores
PAST TOP PICK
(A Top Pick Sep 20/22, Down 10.8%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with CVS has triggered its stop at $90. To remain disciplined, we recommend covering the position at this time. This will result in a net investment loss of 4% when combined with the previous buy recommendations.
specialty stores
HOLD
Shares are down after Washington downgraded its flagship medicare plan. Not a good day. He won't sell it because it's been A strong performer for him, but he won't rule it out. Today's shares dropped 10%. He's holding. There's more to CVS than only the medicare ratings. They still predict low-double-digit earnings growth in coming years. Trades around 11x and pays a 2.2% yield.
specialty stores
TOP PICK
Recent foray into home healthcare, a blossoming theme with consumers. Great growth, smart acquirers. One of the largest in the US. Post-pandemic will see a focus on healthcare. Yield is 2.14%. (Analysts’ price target is $120.86)
specialty stores
TOP PICK
Stockchase Research Editor: Michael O'Reilly We again reiterate this relatively recession proof diversified supplier in the healthcare and insurance space as a TOP PICK. The company recently announced an $8 billion acquisition that launches it into providing data and tech aid and health systems -- undoubtedly to assist their 1100 walk-in clinic locations. It trades at 16x earnings, compared to peers at 33x and it trades at less than 2x book value. The dividend is supported by a payout ratio under 40% of cash flow. We especially like how cash reserves have grown while debt has been retired. We continue to recommend a stop at $90, looking to achieve $121 -- upside over 19%. Yield 2.16% (Analysts’ price target is $120.57)
specialty stores
BUY
Just bought it this week. Really likes them buying Signify, a home healthcare business as the population ages. CVS boasts a 13% cash flow yield and pays a 2% dividend.
specialty stores
TOP PICK
Stockchase Research Editor: Michael O'Reilly We again reiterate CVS, a top retail pharmacy and health care insurance company, as a TOP PICK. The company recently announced it is targeting entry into the primary care space and has cash reserves of $12 billion to do so. It trades at 1.8x book value and forward earnings for next year project a PE of 11x earnings compared to peers at 17x. It pays a good dividend backed by a payout ratio under 35% of cash flow. We like that it has continued to build cash reserves, while aggressively retiring debt and buying back shares. We continue to recommend the trailing stop at $90, looking to achieve $120 -- upside potential of 18%. Yield 2.17% (Analysts’ price target is $120.14)
specialty stores
BUY
Can't argue against Pfizer and JNJ, but he owns CVS. Pfizer is the purest drug play, JNJ has three divisions while CVS is pharmas, primarily, though it also runs insurance. In recent years, the market has recognized CVS as not just a storefront, but operates broader healthcare. The U.S. spends 18% of their GDP on healthcare, while the Western world is below 12%.
specialty stores
BUY
It was a key hub for vaccinations during Covid which attracted customers to its stores. But then shares fell from $111 last February to $88 in mid-June. Last week, CVS reported a strong quarter: 8% same-store sales growth and raised their full-year forecast. Shares jumped 8% ina day and returned above $100. He's very impressed by the new CEO. He really likes their Minute Clinics and a new acquisition could be a good fit.
specialty stores
BUY
It was a key hub for vaccinations during Covid which attracted customers to its stores. But then shares fell from $111 last February to $88 in mid-June. Last week, CVS reported a strong quarter: 8% same-store sales growth and raised their full-year forecast. Shares jumped 8% ina day and returned above $100. He's very impressed by the new CEO. He really likes their Minute Clinics and a new acquisition could be a good fit.
specialty stores
BUY
Allan Tong’s Discover Picks CVS has been paying down debt after buying insurer Aetna three years ago and their balance sheet is in such decent shape that the company recently announced share buybacks, though you may need to wait for a dividend to increase from the current 2.2% based on a low 34% payout ratio. CVS trades a fine 16x PE. The 6.02% EPS marked a 7% rise over the past year. Sales are up 8% YOY and growth is expected around that much. Expect sustainable, moderate growth. (If you want mega, double-digit growth, gamble on Bitcoin.) Read 3 Recession Proof Stocks for our full analysis.
specialty stores
BUY
A steady performer that consistently outperforms. They use their excess cash to pay down debt (to buy Aetna 3 years ago). They recently announced share buybacks and wants to see this increase. This is a long-term investment. They report next week.
specialty stores
TOP PICK
CVS is a major pharmacy benefits manager providing tons of data to large companies lioke GM. He likes the pharmacy business, because it's much cheaper to go to the pharmacy for a vaccine instead of a hospital. Pharmacy will gain market share. CVS will return to dividend increases after their Aetna acqusition. Trades at 10x earnings. Very well-position. This is recession-proof. (Analysts’ price target is $116.70)
specialty stores
BUY
Has owned this for a long time. Are vertically integrated. Their core are the 10,000 pharmacies. Have merged with Caremark, a pharmacy benefit manager, and bought Aetna the health insurer. Great CEO. They write about a billion prescriptions a year. CVS offers stability to a portfolio to offset the cyclical ones.
specialty stores
CVS Health Corp(CVS-N) Rating
Ranking : 5 out of 5
Bullish - Buy Signals / Votes : 21
Neutral - Hold Signals / Votes : 3
Bearish - Sell Signals / Votes : 2
Total Signals / Votes : 26
CVS Health Corp(CVS-N) Frequently Asked Questions
What is CVS Health Corp stock symbol?
CVS Health Corp is a American stock, trading under the symbol CVS-N on the New York Stock Exchange (CVS). It is usually referred to as NYSE:CVS or CVS-N
Is CVS Health Corp a buy or a sell?
In the last year, 26 stock analysts published opinions about CVS-N. 21 analysts recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for CVS Health Corp.
Is CVS Health Corp a good investment or a top pick?
CVS Health Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for CVS Health Corp.
Why is CVS Health Corp stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is CVS Health Corp worth watching?
26 stock analysts on Stockchase covered CVS Health Corp In the last year. It is a trending stock that is worth watching.
What is CVS Health Corp stock price?
On 2022-11-28, CVS Health Corp (CVS-N) stock closed at a price of $100.8.
